[1]Siegel R L , Miller K D , Jemal A . Cancer statistics, 2020[J]. CA: A Cancer Journal for Clinicians, 2020, 70(1).
[2]Motzer R J , Jonasch E , Agarwal N , et al. Kidney cancer, version 3.2015[J]. J Natl Compr Canc Netw, 2015, 13(2):151-159.
[3]Tsivian M, Moreira DM, Caso JR, Mouraviev V, Polascik TJ. Cigarette smoking is associated with advanced renal cell carcinoma. J Clin Oncol. 2011;29(15):2027–2031. doi: 10.1200/JCO.2010.30.9484.
[4]Pischon T, Lahmann PH, Boeing H, Tjonneland A, Halkjaer J, Overvad K, Klipstein-Grobusch K. et al. Body size and risk of renal cell carcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC) Int J Cancer. 2006;118(3):728–738. doi: 10.1002/ijc.21398.
[5]Wozniak MB, Brennan P, Brenner DR, Overvad K, Olsen A, Tjonneland A, Boutron-Ruault MC. et al. Alcohol consumption and the risk of renal cancers in the European prospective investigation into cancer and nutrition (EPIC) Int J Cancer. 2015;137(8):1953–1966. doi: 10.1002/ijc.29559.
[6]Weikert S, Boeing H, Pischon T, Weikert C, Olsen A, Tjonneland A, Overvad K. et al. Blood pressure and risk of renal cell carcinoma in the European prospective investigation into cancer and nutrition. Am J Epidemiol. 2008;167(4):438–446. doi: 10.1093/aje/kwm321
[7]Moore LE, Boffetta P, Karami S, Brennan P, Stewart PS, Hung R, Zaridze D. et al. Occupational trichloroethylene exposure and renal carcinoma risk: evidence of genetic susceptibility by reductive metabolism gene variants. Cancer Res. 2010;70(16):6527–6536. doi: 10.1158/0008-5472.CAN-09-4167.
[8]Choueiri TK, Je Y, Cho E. Analgesic use and the risk of kidney cancer: a meta-analysis of epidemiologic studies. Int J Cancer. 2014;134(2):384–396. doi: 10.1002/ijc.28093.
[9]Klatte T , Rossi S H , Stewart G D . Prognostic factors and prognostic models for renal cell carcinoma: a literature review[J]. World Journal of Urology, 2018.
[10]Lucca I, de Martino M, Hofbauer SL et al (2015) Comparison of the prognostic value of pretreatment measurements of systemic infammatory response in patients undergoing curative resection of clear cell renal cell carcinoma. World J Urol 33:2045–2052
[11]Haas NB, Manola J, Uzzo RG et al (2016) Adjuvant sunitinib or sorafenib for high-risk, non-metastatic renal-cell carcinoma (ECOG-ACRIN E2805): a double-blind, placebo-controlled, randomised, phase 3 trial. Lancet 387:2008–2016
[12]Sung, H. et al. “Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.” CA Cancer J. Clin. https://doi.org/10.3322/caac.21660 (2021).
[13]FUCHS Y, STELLER H. Programmed cell death in animal development and disease. Cell, 2011,147 (4): 742-758.
[14]STOCKWELLBR, FRIEDMANN ANGELIJP, BAYIR H, et al. Ferroptosis: aregulated cell death Nexuslinking metabolism, redox biology, and disease. Cell, 2017,171(2): 273-285.
[15]ALIM I, CAULFIELD J T, CHEN Y X, et al. Selenium drives a transcriptional adaptive program to block ferroptosis and treat stroke. Cell, 2019,177( 5): 1262-1279.
[16]WENZEL S E, TYURINA Y Y, ZHAO J M, et al. PEBP1 wardens ferroptosis by enabling lipoxygenase generation of lipid death signals. Cell, 2017,171 (3): 628-641.
[17]JIANGL, KONN, LI T, et al. Ferroptosis as a p53- mediated activity during tumour suppression. Nature, 2015,520(7545): 57-62.
[18]ZHANGY, SHIJ, LIU X, et al. BAP1 links metabolic regulation of ferroptosis to tumour suppression. Nat Cell Biol, 2018,20(10): 1181-1192.
[19]HANGAUER M J, VISWANATHAN V S, RYAN M J, et al. Drug-tolerant persister cancer cells are vulnera-ble to GPX4 inhibition. Nature, 2017,551(7679): 247-250.
[20]VISWANATHAN V S, RYAN M J, DHRUV H D, et al. Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway. Nature, 2017, 547(7664): 453-457.
[21]WANG W M, GREEN M, CHOI J E, et al. CD8+ T cells regulate tumour ferroptosis during cancer immuno-therapy. Nature, 2019,569(7755): 270-274.
[22]CONRAD M, LORENZ, M, PRONETH B. Targeting ferroptosis: new hope for as-yet-incurable diseases. Trends Mol Med,2020,27(2):113-122.
[23]ELGENDY S M, ALYAMMAHI S K, ALHAMAD D W, et al. Ferroptosis: an emerging approach for targeting cancer stem cells and drug resistance. Crit Rev Oncol Hematol,2020,155:103095.
[24]ALA M, MOHAMMAD JAFARI R, AGBELE A T, et al. Sumatriptan alleviates radiation-induced oral mucositis in rats by inhibition of NF-kB and ERK activation, prevention of TNF-α and ROS release. Arch Oral Biol,2020,119:104919.
[25]Friedmann Angeli, J. P., Krysko, D. V., and Conrad, M. (2019). Ferroptosis at the crossroads of cancer-acquired drug resistance and immune evasion. Nat. Rev. Cancer 19, 405-414. doi: 10.1038/s41568-019-0149-1.
[26]Ferrone C.R., Kattan M.W., Tomlinson J.S., Thayer S.P., Brennan M.F., Warshaw A.L. Validation of a postresection pancreatic adenocarcinoma nomogram for disease-specific survival. J Clin Oncol. 2005;23:7529-7535.
[27]Li T, Fan J, Wang B, Traugh N, Chen Q, Liu JS, et al. TIMER: A web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res. (2017)77: e108-10. doi: 10.1158/0008-5472.
[28]Ye Z, Wang F, Yan F, et al. Bioinformatic identification of candidate biomarkers and related transcription factors in nasopharyngeal carcinoma. World J Surg Oncol 2019;17(1):60.
[29]Zhou G, Soufan O, Ewald J, et al. NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis. Nucleic Acids Res 2019;47(W1):W234-41.
[30]Liu ZP, Wu C, Miao H, et al. RegNetwork: an integrated database of transcriptional and post-transcriptional regulatory networks in human and mouse. Database. 2015;2015:bav095.
[31]Xia J, Gill EE, Hancock RE. NetworkAnalyst for statistical,visual and network-based meta-analysis of gene expression data. Nat Protoc 2015;10(6):823.
[32]Therneau TM (2015) A package for survival analysis in S. Version 2.38. CRAN website-https://cran.r-project.org/package=survival.
[33]Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018, 68(1): 7-30.
[34]Brierley JD, Gospodarowicz MK, Wittekind C, et al. TNM Classification of Malignant Tumours. [M]. 8th ed. Chichester: Wiley-Blackwell. 2016: 187-210.
[35]Phan T, Nguyen V.H, A lincourt Salazar M, Wong P, Diamond D.J, Yim J.H, Melstrom L.G. Inhibition of Autophagy Amplifies Baicalein-Induced Apoptosis in Human Colorectal Cancer. Mol Ther Oncolytics. 2020;19:1-7.
[36]Yang B.C, Leung P.S. Irisin Is a Positive Regulator for Ferroptosis in Pancreatic Cancer. Mol Ther Oncolytics. 2020;18:457-466.
[37]Wang W, Green M, Choi J.E, et al. CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy. Nature. 2019;569:270-274.
[38]SUN X F, NIU X H, CHEN R C, et al. Metallothionein-1G facilitates sorafenib resistance through inhibition of ferroptosis. Hepatology,2016,64(2):488-500.
[39]YuanfengLiu, Dongting Zhao, Wenyi Peng, et al. Atmospheric PM2.5 blocking up autophagic flux in HUVECs via inhibiting Sntaxin-17 and LAMP2. Ecotoxicology and Environmental Safety. Volume 208, 2021.
[40]Nayak B, et al. Modulation of renal-specific oxidoreductase/myo-inositol oxygenase by high-glucose ambience. Proc Natl Acad Sci USA. 2005;102(50):17952-17957.
[41]Sharma I, Dutta RK, Singh NK, Kanwar YS. High glucose-induced hypomethylation promotes binding of Sp-1 to Myo-inositol oxygenase: implication in the pathobiology of diabetic tubulopathy. Am J Pathol. 2017;187(4):724-739.
[42]Sharma I, Tupe RS, Wallner AK, Kanwar YS. Contribution of myo-inositol oxygenase in AGE: RAGE-mediated renal tubulointerstitial injury in the context of diabetic nephropathy. Am J Physiol Renal Physiol. 2018;314(1):F107-F121.
[43]Liang J.Y, Wang D.S, Lin H.C, Chen X.X, Yang H, Zheng Y, Li Y.H. A Novel Ferroptosis-related Gene Signature for Overall Survival Prediction in Patients with Hepatocellular Carcinoma. Int J Biol Sci. 2020;16:2430-2441
[44]Liu H.J, Hu H.M, Li G.Z, Zhang Y, Wu F, Liu X, Wang K.Y, Zhang C.B, Jiang T. Ferroptosis-Related Gene Signature Predicts Glioma Cell Death and Glioma Patient Progression. Front. Cell Dev. Biol. 2020;8:538.